Clinical Trial Update: Intranasal Midazolam for Treatment of Anxiety in Children Undergoing Suturing in the Pediatric Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated intranasal midazolam to reduce anxiety in children undergoing suturing in the pediatric emergency department; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Anxiety, Lacerations | Phase 4 | Status: COMPLETED | Results posted: 2016-10-07